Systemic treatment for severe psoriasis in a patient with autoimmune cytopenia

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

A rare cause of cytopenia in a patient with systemic lupus erythematosus: Autoimmune myelofibrosis.

Hematological abnormalities are very common in the course of systemic lupus erythematosus (SLE). Myelofibrosis is a bone marrow disorder in which there is excessive fibrous tissue formation in the bone marrow. Various benign and malignant disorders can cause or be associated with a diffuse increase in the bone marrow reticular tissue. Some diseases such as infections, neoplasms, and autoimmune ...

متن کامل

Experience with the systemic treatment of severe forms of psoriasis.

INTRODUCTION Severe forms of psoriasis are indicated for systemic treatment with conventional and biological preparations. The former includes methotrexate, cyclosporin, acitretin and narrow-band ultraviolet B phototherapy but toxicity may limit the dose and duration of treatment. Currently used less toxic biological preparations include inhibitors of TNF-alpha (etanercept, adalimumab, inflixim...

متن کامل

Successful Treatment with Rituximab in a Patient with Castleman's Disease Complicated by Systemic Lupus Erythematosus and Severe Autoimmune Thrombocytopenia

Correspondence To the Editor: A 44‑year‑old man with no remarkable past medical history, was admitted with 1‑month history of fever and lymphadenopathy. He also had night sweats, malaise, arthralgia, urine volume reduction, abdominal distention, and weight loss. Physical examination revealed swollen lymph nodes in the neck, axillary fossae and inguinal grooves, palpable liver and spleen, shifti...

متن کامل

Systemic combination treatment for psoriasis: a review.

Psoriasis is a chronic inflammatory skin disease, which affects approximately 2.6% of the population in Northern Europe and Scandinavia. In order to achieve disease control, combinations of systemic treatments are sometimes needed for variable time periods. However, no evidence-based guidelines exist for the use of systemic combination therapy. Therefore, our aim was to review the current liter...

متن کامل

Refractory Angioedema in a Patient with Systemic Lupus Erythematosus

Angioedema secondary to C1 inhibitor deficiency has been rarely reported to be associated with systemic lupus erythematosus. A genetic defect of C1 inhibitor produces hereditary angioedema, which is usually presented with cutaneous painless edema, but edema of the genital area, gastrointestinal and laryngeal tracts have also been reported.In lupus patients, angioedema may be the result of an ac...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: International Journal of Women's Dermatology

سال: 2020

ISSN: 2352-6475

DOI: 10.1016/j.ijwd.2020.03.010